Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07739953) titled 'Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary Syndrome' on July 28.

Study Type: Observational

Primary Sponsor: Guangdong Women and Children Hospital

Condition: PCOS (Polycystic Ovary Syndrome)

Intervention: Other: observational study

Recruitment Status: Not recruiting

Date of First Enrollment: June 1, 2025

Target Sample Size: 200

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07739953

Disclaimer: Curated by HT Syndication....